Regulatory Information
HSA regulatory responsibility and product classification details
Regulatory Responsibility
RegistrantNOVARTIS (SINGAPORE) PTE LTD
Product Classification
D
Drug Type
Therapeutic
F
Forensic Class
Prescription Only
HSA Singapore Classification
Formulation Information
CAPSULE
ORAL
Medical Information
L01EF01
Manufacturer Information
NOVARTIS (SINGAPORE) PTE LTD
Aizant Drug Research Solutions Pvt Ltd.
Active Ingredients
Documents
Package Inserts
PALBOCICLIB SANDOZ Capsule PI.pdf
Approved: May 9, 2024